inicarone

Also Known As:

L 7035; isopropyl-2-isonicotinyl-3-benzofuran; (2-(1-methylethyl)-3-benzofuranyl)-4-pyridinylmethanone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Lewis Lung Carcinoma 10/01/1983 - "The effect of inicarone (L7035), a potent fibrinolytic, alone or in combination, was investigated on spontaneously metastasizing Lewis lung carcinoma (implanted intramuscularly) to verify whether it could prevent the formation of metastases. "
2.	Neoplasm Metastasis (Metastasis) 10/01/1983 - "The effect of inicarone (L7035), a potent fibrinolytic, alone or in combination, was investigated on spontaneously metastasizing Lewis lung carcinoma (implanted intramuscularly) to verify whether it could prevent the formation of metastases. " 10/01/1983 - "Moreover, when inicarone was combined with a potent antimetastatic agent, Nocodazole, it was shown to be in competition with the latter agent and totally overshadowed its activity; since inicarone had no antimetastatic effect, the number of metastases rose dramatically." 10/01/1983 - "When administered in combination with cyclophosphamide, an antiproliferative agent, inicarone did not induce any synergism or antagonism, but this combination did not inhibit tumour growth or metastasis spreading. " 10/01/1983 - "Its activity was compared to that of warfarin, an anticoagulant: both drugs were inactive when administered in curative treatment and inicarone even enhanced the number of lung metastases. "